Clinical Validation of Stool DNA-based SDC2 Methylation Test for Colorectal Cancer Detection

NCT03146520 COMPLETED

Pivotal trials of SDC2 methylation biomarker test in stool DNA to estimate clinical sensitivity and specificity in detection of colorectal cancer.

Details

Lead sponsor	Genomictree, Inc.
Status	COMPLETED
Enrolment	634
Start date	Tue Dec 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Mar 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Colorectal Cancer
• Polyps
• Other Cancers
• Healthy

Interventions

• EarlyTect Colon Cancer

Countries

South Korea